262 related articles for article (PubMed ID: 22153026)
1. Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.
Liem TK; Deloughery TG
Semin Vasc Surg; 2011 Sep; 24(3):157-61. PubMed ID: 22153026
[TBL] [Abstract][Full Text] [Related]
2. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
3. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
4. Warfarin versus dabigatran: comparing the old with the new.
Abraham ME; Marcy TR
Consult Pharm; 2012 Feb; 27(2):121-4. PubMed ID: 22330953
[TBL] [Abstract][Full Text] [Related]
5. Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.
Khemasuwan D; Suramaethakul N
Clin Appl Thromb Hemost; 2012 Sep; 18(5):476-86. PubMed ID: 22387584
[TBL] [Abstract][Full Text] [Related]
6. Treatment of venous thromboembolism with dabigatran.
Schulman S
Curr Opin Pulm Med; 2012 Sep; 18(5):410-5. PubMed ID: 22617811
[TBL] [Abstract][Full Text] [Related]
7. New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.
Morris TA
Clin Chest Med; 2010 Dec; 31(4):707-18. PubMed ID: 21047577
[TBL] [Abstract][Full Text] [Related]
8. The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
Diener HC; Eikelboom J; Granger CB; Hacke W
Int J Stroke; 2012 Feb; 7(2):139-41. PubMed ID: 22264366
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
Zikria J; Ansell J
Discov Med; 2009 Dec; 8(43):196-203. PubMed ID: 20040270
[TBL] [Abstract][Full Text] [Related]
10. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
11. [Dabigatran, a new oral anticoagulant].
Uchiyama S
Brain Nerve; 2011 Apr; 63(4):411-5. PubMed ID: 21441645
[TBL] [Abstract][Full Text] [Related]
12. Implications of Dabigatran, a direct thrombin inhibitor, for oral surgery practice.
Davis C; Robertson C; Shivakumar S; Lee M
J Can Dent Assoc; 2013; 79():d74. PubMed ID: 23920075
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Friedman RJ
Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
[TBL] [Abstract][Full Text] [Related]
14. New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism.
den Exter PL; Kooiman J; van der Hulle T; Huisman MV
Best Pract Res Clin Haematol; 2013 Jun; 26(2):163-9. PubMed ID: 23953904
[TBL] [Abstract][Full Text] [Related]
15. [New oral anticoagulants for treatment of venous thromboembolism].
Espinola-Klein C; Weisser G
Dtsch Med Wochenschr; 2011 Jun; 136(22):1162-4. PubMed ID: 21611919
[TBL] [Abstract][Full Text] [Related]
16. [New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
Blanco-Molina A
Rev Clin Esp; 2012 Jan; 212 Suppl 1():3-7. PubMed ID: 23117646
[TBL] [Abstract][Full Text] [Related]
17. New anticoagulants for the treatment of venous thromboembolism.
Prandoni P; Dalla Valle F; Piovella C; Tormene D; Pesavento R
Minerva Med; 2013 Apr; 104(2):131-39. PubMed ID: 23514989
[TBL] [Abstract][Full Text] [Related]
18. [New anticoagulants in the prevention and treatment of venous thromboembolism].
Keltai M; Keltai K
Orv Hetil; 2011 Jun; 152(25):983-92. PubMed ID: 21642050
[TBL] [Abstract][Full Text] [Related]
19. [New oral anticoagulants in the treatment of venous thromboembolic disease].
Calvo Romero JM; Lima Rodríguez EM
Semergen; 2013 Apr; 39(3):146-9. PubMed ID: 23540987
[TBL] [Abstract][Full Text] [Related]
20. [Waiting for the new oral anticoagulants: questions and answers about dabigatran].
Verdecchia P; Agnelli G
G Ital Cardiol (Rome); 2013 Jan; 14(1):35-45. PubMed ID: 23258203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
